SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.